Not applicableStudy completedNCT00002149What this trial is testingAcupuncture and Herbal Treatment of Chronic HIV SinusitisWho this might be right forHIV InfectionsSinusitis Immune Enhancement Project 40
Not applicableStudy completedNCT00116415What this trial is testingDART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral TherapyWho this might be right forHIV InfectionsAIDS Bristol-Myers Squibb 65
Testing effectiveness (Phase 2)Study completedNCT00000918What this trial is testingCompare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment FailureWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableUnknownNCT00216359What this trial is testingCohort Study for Patients Using Fuzeon (Enfuvirtide)Who this might be right forHIV InfectionsAntiretroviral Treatment Institute for Interdisciplinary Infectiology 200
Large-scale testing (Phase 3)Ended earlyNCT00144833What this trial is testingOpen Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV SubjectsWho this might be right forHIV-1 GlaxoSmithKline 150
Post-approval studies (Phase 4)Study completedNCT00005764What this trial is testingIncreased Lactic Acid and Abnormal Fat Distribution in HIV-Positive PatientsWho this might be right forHIV InfectionsLipodystrophy Glaxo Wellcome 100
Not applicableStudy completedNCT00002426What this trial is testingA Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive PatientsWho this might be right forHIV Infections Gilead Sciences 390
Large-scale testing (Phase 3)Study completedNCT02032888What this trial is testingEvaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.Who this might be right forHepatitis C Bristol-Myers Squibb 238
Testing effectiveness (Phase 2)Study completedNCT00380159What this trial is testingOpen-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014AWho this might be right forHuman Immunodeficiency Virus (HIV)-1 Infection Alexion Pharmaceuticals, Inc. 4
Testing effectiveness (Phase 2)UnknownNCT06240520What this trial is testingOptimizing Reversal of HIV Latency With Combination TherapyWho this might be right forHiv Erasmus Medical Center 49
Early research (Phase 1)Study completedNCT06031272What this trial is testingPausing Antiretroviral Treatment Under Structured EvaluationWho this might be right forHIV-1-infection Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 32
Early research (Phase 1)Study completedNCT00000970What this trial is testingFoscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With GanciclovirWho this might be right forCytomegalovirus RetinitisHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00000901What this trial is testingSafety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected ChildrenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00979420What this trial is testingNon-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With ViramuneWho this might be right forHIV Infections Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT00002324What this trial is testingThe Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the DiseaseWho this might be right forHIV Infections Boehringer Ingelheim 250
Not applicableStudy completedNCT00002215What this trial is testingA Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-NaiveWho this might be right forHIV Infections Triangle Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00098748What this trial is testingTrial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected SubjectsWho this might be right forHIV Infections ViiV Healthcare 190
Not applicableStudy completedNCT00002168What this trial is testingA Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected PatientsWho this might be right forHIV Infections Bristol-Myers Squibb 200
Testing effectiveness (Phase 2)Study completedNCT00312091What this trial is testingDrug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT00016718What this trial is testingSafety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV DrugsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 43